Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Rapid synthesis of platinum-ruthenium bimetallic nanoparticles dispersed on carbon support as improved electrocatalysts for ethanol oxidation.

Gu Z, Li S, Xiong Z, Xu H, Gao F, Du Y.

J Colloid Interface Sci. 2018 Jul 1;521:111-118. doi: 10.1016/j.jcis.2018.03.035. Epub 2018 Mar 13.

PMID:
29558690
2.

Observation of deformation twinning and martensitic transformation during nanoindentation of a transformation-induced plasticity steel.

Xiong Z, Casillas G, Saleh AA, Cui S, Pereloma EV.

Sci Rep. 2017 Dec 12;7(1):17397. doi: 10.1038/s41598-017-17824-x.

3.

Fabrication of "Plug and Play" Channels with Dual Responses by Host-Guest Interactions.

Liu N, Li C, Zhang T, Hou R, Xiong Z, Li Z, Wei B, Yang Z, Gao P, Lou X, Zhang X, Guo W, Xia F.

Small. 2017 Jan;13(4). doi: 10.1002/smll.201600287. Epub 2016 May 9.

PMID:
27158970
4.

Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein.

Pouliot JJ, Thomson M, Xie M, Horton J, Johnson J, Krull D, Mathis A, Morikawa Y, Parks D, Peterson R, Shimada T, Thomas E, Vamathevan J, Van Horn S, Xiong Z, Hamatake R, Peat AJ.

Antimicrob Agents Chemother. 2015 Oct;59(10):6539-50. doi: 10.1128/AAC.00813-15. Epub 2015 Aug 10.

5.

Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein.

Tai VW, Garrido D, Price DJ, Maynard A, Pouliot JJ, Xiong Z, Seal JW 3rd, Creech KL, Kryn LH, Baughman TM, Peat AJ.

Bioorg Med Chem Lett. 2014 May 15;24(10):2288-94. doi: 10.1016/j.bmcl.2014.03.080. Epub 2014 Apr 3.

PMID:
24731273
6.

Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.

Maynard A, Crosby RM, Ellis B, Hamatake R, Hong Z, Johns BA, Kahler KM, Koble C, Leivers A, Leivers MR, Mathis A, Peat AJ, Pouliot JJ, Roberts CD, Samano V, Schmidt RM, Smith GK, Spaltenstein A, Stewart EL, Thommes P, Turner EM, Voitenleitner C, Walker JT, Waitt G, Weatherhead J, Weaver K, Williams S, Wright L, Xiong ZZ, Haigh D, Shotwell JB.

J Med Chem. 2014 Mar 13;57(5):1902-13. doi: 10.1021/jm400317w. Epub 2013 May 29.

PMID:
23672667
7.

Hepatitis C replication inhibitors that target the viral NS4B protein.

Miller JF, Chong PY, Shotwell JB, Catalano JG, Tai VW, Fang J, Banka AL, Roberts CD, Youngman M, Zhang H, Xiong Z, Mathis A, Pouliot JJ, Hamatake RK, Price DJ, Seal JW 3rd, Stroup LL, Creech KL, Carballo LH, Todd D, Spaltenstein A, Furst S, Hong Z, Peat AJ.

J Med Chem. 2014 Mar 13;57(5):2107-20. doi: 10.1021/jm400125h. Epub 2013 Apr 19.

PMID:
23544424
8.

Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization.

Shotwell JB, Baskaran S, Chong P, Creech KL, Crosby RM, Dickson H, Fang J, Garrido D, Mathis A, Maung J, Parks DJ, Pouliot JJ, Price DJ, Rai R, Seal JW 3rd, Schmitz U, Tai VW, Thomson M, Xie M, Xiong ZZ, Peat AJ.

ACS Med Chem Lett. 2012 May 24;3(7):565-9. doi: 10.1021/ml300090x. eCollection 2012 Jul 12.

9.

Discovery of a novel series of cyclic urea as potent CCR5 antagonists.

Duan M, Kazmierski WM, Tallant M, Jun JH, Edelstein M, Ferris R, Todd D, Wheelan P, Xiong Z.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6381-5. doi: 10.1016/j.bmcl.2011.08.096. Epub 2011 Aug 28.

PMID:
21930378
10.

Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats.

Duan M, Kazmierski WM, Chong PY, Deanda F, Edelstein M, Ferris R, Peckham J, Wheelan P, Xiong Z, Zhang H, Nishizawa R, Takaoka Y.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6470-5. doi: 10.1016/j.bmcl.2011.08.080. Epub 2011 Aug 23.

PMID:
21920742
11.

Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): modification of the acyl portion.

Duan M, Peckham J, Edelstein M, Ferris R, Kazmierski WM, Spaltenstein A, Wheelan P, Xiong Z.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7401-4. doi: 10.1016/j.bmcl.2010.10.042. Epub 2010 Oct 21.

PMID:
21055933
12.

Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): optimization of the amine portion.

Duan M, Peckham J, Edelstein M, Ferris R, Kazmierski WM, Spaltenstein A, Wheelan P, Xiong Z.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7397-400. doi: 10.1016/j.bmcl.2010.10.033. Epub 2010 Oct 12.

PMID:
21035337

Supplemental Content

Loading ...
Support Center